<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<title>Yichang Zhao – Academic Homepage</title>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;600;700&display=swap" rel="stylesheet" />
<style>
  body {
    margin: 0;
    font-family: "Inter", sans-serif;
    background: #ffffff;
    color: #111;
    line-height: 1.7;
  }
  header {
    text-align: center;
    padding: 50px 20px 20px;
  }
  header img {
    width: 150px;
    border-radius: 8px;
  }
  header h1 {
    margin: 20px 0 5px;
    font-size: 2.4rem;
    font-weight: 700;
  }
  header p {
    font-size: 1.1rem;
    opacity: 0.8;
  }
  .container {
    max-width: 850px;
    margin: 40px auto;
    padding: 20px;
  }
  h2 {
    margin-top: 40px;
    font-size: 1.4rem;
    font-weight: 700;
    border-bottom: 1px solid #ddd;
    padding-bottom: 6px;
  }
  ul {
    padding-left: 20px;
  }
  li { margin-bottom: 8px; }
  a {
    color: #003366;
    text-decoration: none;
    font-weight: 600;
  }
  a:hover { text-decoration: underline; }
  .footer {
    text-align: center;
    padding: 40px;
    font-size: 0.9rem;
    color: #666;
  }
</style>
</head>

<body>

<header>
  <img src="/mnt/data/ae99a380-06d6-46c3-a2d3-a03db4c203da.png" alt="Profile Photo" />
  <h1>Yichang Zhao</h1>
  <p>PhD Candidate · Clinical Pharmacy · The Second Xiangya Hospital, Central South University</p>
</header>

<div class="container">

<h2>About</h2>
<p>Email: <a href="mailto:zhaoyichang@csu.edu.cn">zhaoyichang@csu.edu.cn</a></p>
<p>ORCID: <a href="https://orcid.org/0000-0002-9651-4457">0000-0002-9651-4457</a></p>

<p>
Research activities focus on antimicrobial pharmacology, infectious disease epidemiology,
and clinical pharmacokinetics. Current work emphasizes optimization of antimicrobial therapy,
characterization of PK/PD variability, and identification of clinical and environmental determinants
of antimicrobial resistance. Quantitative methodologies—including meta-analysis, population pharmacokinetic (PopPK)
modeling, real-world evidence analysis, and causal inference—are applied to support individualized dosing
strategies and evidence-based antimicrobial stewardship.
</p>

<p>
Published research includes multiple first-author articles in internationally peer-reviewed journals
spanning pharmacology, infectious diseases, and environmental health. Long-term objectives involve integrating
translational pharmacology with data-driven infectious disease research to improve therapeutic decision-making
for severe and drug-resistant infections.
</p>

<h2>Employment</h2>
<ul>
  <li><strong>Second Xiangya Hospital of Central South University</strong>, Changsha, Hunan, China (2017–2019)<br>
      Administrative Secretary, GCP Office & Medical Ethics Committee</li>
  <li><strong>First Affiliated Hospital of Hunan University of Medicine</strong>, Huaihua, China (2014–2015)<br>
      Clinical Pharmacist</li>
</ul>

<h2>Education</h2>
<ul>
  <li><strong>Ph.D., Clinical Pharmacy</strong> (2022–2026)<br>
      The Second Xiangya Hospital, Central South University</li>
  <li><strong>Master of Clinical Pharmacy</strong> (2019–2022)<br>
      The Second Xiangya Hospital, Central South University</li>
  <li><strong>Bachelor of Pharmacy</strong> (2010–2014)<br>
      Xiangya School of Medicine, Central South University</li>
</ul>

<h2>Distinctions & Honors</h2>
<ul>
  <li>National Doctoral Scholarship – Ministry of Education (2022, 2024, 2025)</li>
  <li>Selected Young Scientist – 72nd Lindau Nobel Laureate Meeting (NSFC–DFG Sino-German Center)</li>
  <li>Person of the Year – Central South University (2023)</li>
  <li>CSU Innovation Award · President’s Scholarship (2023)</li>
</ul>

<h2>Funding</h2>
<ul>
  <li><strong>NIHAYSZX2502</strong> – IoT- and GIS-Based System for CR-GNB Infection Warning and Precision Medication<br>
      National Health Commission of the People’s Republic of China</li>
  <li><strong>202113012480</strong> – Voriconazole Dosing Adjustment in Hepatic Dysfunction<br>
      Health Commission of Hunan Province</li>
</ul>

<h2>Selected Publications</h2>
<p>Full 30-publication list available on <a href="https://scholar.google.com/citations?user=ZrNKcgIAAAAJ">Google Scholar</a>.</p>
<ul>
  <li>BMC Medical Education (2025) – DOI: 10.1186/s12909-025-07859-4</li>
  <li>Cardiovascular Diabetology (2025) – DOI: 10.1186/s12933-025-02880-9</li>
  <li>Environmental Sciences Europe (2025) – DOI: 10.1186/s12302-025-01111-y</li>
  <li>Frontiers in Pharmacology (2025) – DOI: 10.3389/fphar.2025.1534107</li>
  <li>Scientific Reports (2025) – DOI: 10.1038/s41598-025-91356-7</li>
  <li>Environmental Geochemistry and Health (2024) – DOI: 10.1007/s10653-024-02264-0</li>
  <li>Frontiers in Pharmacology (2024) – DOI: 10.3389/fphar.2024.1439232</li>
  <li>IJAA (2024) – DOI: 10.1016/j.ijantimicag.2024.107262</li>
  <li>Environmental Research (2024) – DOI: 10.1016/j.envres.2023.117995</li>
  <li>Phytomedicine (2023) – DOI: 10.1016/j.phymed.2023.154883</li>
  <li>Pharmaceutics (2022) – DOI: 10.3390/pharmaceutics14122739</li>
  <li>Antibiotics (2022) – DOI: 10.3390/antibiotics11050670</li>
  <li>Infectious Diseases and Therapy (2022) – DOI: 10.1007/s40121-021-00551-2</li>
  <li>British Journal of Clinical Pharmacology (2021) – DOI: 10.1111/bcp.14578</li>
  <li>Clinical and Translational Science (2021) – DOI: 10.1111/cts.12932</li>
</ul>

<h2>Links</h2>
<ul>
  <li><a href="https://orcid.org/0000-0002-9651-4457">ORCID</a></li>
  <li><a href="https://scholar.google.com/citations?user=ZrNKcgIAAAAJ">Google Scholar</a></li>
  <li><a href="https://www.researchgate.net/profile/Yichang-Zhao">ResearchGate</a></li>
</ul>

</div>

<div class="footer">
  © 2025 Yichang Zhao · Academic Homepage
</div>

</body>
</html>
